KBP-066 is a dual amylin and calcitonin (CT) receptor agonist.1 It induces β-arrestin recruitment in cells expressing CT receptor subtype a or the amylin 3 receptor (AMY3) in a concentration-dependent manner. KBP-066 (50 ?g/kg) reduces body weight and food intake in rats fed a high-fat diet. It prevents increases in fasting blood glucose levels in fa/fa Zucker diabetic fatty rats.
References:
[1]. Sonne, N., Larsen, A.T., Andreassen, K.V., et al.The dual amylin and calcitonin receptor agonist, KBP-066, induces an equally potent weight loss across a broad dose range while higher doses may further improve insulin actionJ. Pharmacol. Exp. Ther.373(1)92-102(2020).
















